Landiolol Recruiting Phase 3 Trials for Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03779178Landiolol in Postoperative Atrial Fibrillation